Test Price
2,800 AED✅ Home Collection Available
KCNE1 Gene Long QT Syndrome Type 5 Genetic Test in UAE | 2800 AED | DHA Licensed Laboratory
Executive Summary & Core Metrics
Targeted Genetic Risk Assessment for Long QT Syndrome 5
- ✓ 99.9% Diagnostic Sensitivity – ISO‑accredited NGS analysis with variant interpretation per ACMG guidelines.
- ✓ VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection – Available daily from 8 AM to 11 PM for blood, extracted DNA, or FTA card.
- ✓ Telephonic Post‑Test Guidance – Expert clinical interpretation of results with a specialist genetic counsellor.
- ✓ Direct Insurance Verification – WhatsApp +971 54 548 8731 for instant eligibility check before sampling.
Test Overview & Methodology
The KCNE1 Gene Long QT Syndrome Type 5 Genetic Test is a targeted molecular diagnostic that screens for pathogenic variants in the KCNE1 gene associated with inherited cardiac arrhythmia. This test empowers cardiologists, geneticists, and informed individuals to clarify personal risk, guide therapy, and initiate family cascade screening with a simple blood or buccal sample.
Test at a Glance
| Aspect | Our Test | Closest Alternative |
|---|---|---|
| Precision | Targeted NGS with complete KCNE1 coverage, variant validation via Sanger | Whole-exome sequencing (incidental findings possible, lower depth) |
| Methodology | ISO‑certified Illumina NGS platform, bioinformatic ACMG classification | Research‑grade panels or older Sanger‑only approaches |
| Turnaround | 3‑4 Weeks with pre‑ and post‑test genetic counselling | 6‑10 Weeks, often without integrated counselling |
| Logistics | Home collection by certified phlebotomist, cold chain, FTA card option | Clinic visit required; limited sample stability |
Physician Insight & Safety Protocols
“Understanding your genetic predisposition to Long QT syndrome is a courageous first step. Our laboratory delivers definitive molecular data, but every result must be correlated with a full cardiac evaluation by your cardiologist. I urge you to continue all prescribed medications and discuss any lifestyle changes with your doctor before acting on genetic findings.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Critical Medication Notice
Do not discontinue any prescribed medication, especially beta‑blockers or anti‑arrhythmics, without consulting your treating physician. Abrupt changes can trigger life‑threatening arrhythmias.
Exclusion Criteria & Emergency Red Flags
- • This test is not a substitute for emergency cardiac care. If you experience chest pain, syncope (fainting), or fast/irregular palpitations, call 998 immediately.
- • Not suitable for individuals without prior clinical assessment for Long QT syndrome symptoms or family history.
- • Minors (<18 years) require legally authorised guardian consent and a referral from a paediatric cardiologist.
- • Patients currently hospitalised for acute arrhythmic events should postpone genetic testing until stabilised.
Patient FAQ & Clinical Guidance
1. What does the KCNE1 gene test detect, and who should consider it?
Expert Snippet: The test identifies inherited mutations in KCNE1 linked to Long QT syndrome type 5, enabling precise risk stratification and family screening.
This test is recommended for individuals with a personal or family history of unexplained syncope, sudden cardiac arrest, or prolonged QT interval on ECG, as well as for cascade testing of relatives after a positive diagnosis.
2. How is the sample collected and what preparation is needed?
Expert Snippet: A certified phlebotomist collects a blood sample, extracted DNA, or a simple finger‑prick on an FTA card during a scheduled home visit.
No fasting is required. A mandatory pre‑test genetic counselling session is conducted to document clinical history and draw a detailed pedigree. The sample remains stable in our cold‑chain transport system until processing.
3. Will I receive genetic counselling along with my results?
Expert Snippet: Yes, our service includes both pre‑ and post‑ counselling with a licensed genetic counsellor to explain findings and implications.
After the laboratory analysis, a personalised telephonic session explains your variant report, its clinical relevance, and next steps for family members. A written, DHA‑compliant report is provided.
UAE Regulatory & Data Privacy Adherence
Data Protection: All personal and genetic data processed by DNA Labs UAE is handled in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent is obtained and managed per Federal Decree-Law No. 4 of 2016 on Medical Liability. No data is shared with third parties without explicit authorisation.
Clinical Oversight: This test is clinically overseen by Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403), ensuring adherence to DHA diagnostic standards.
Clinical & Logistical Metadata
| Test Name | KCNE1 Gene Long QT Syndrome Type 5 Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral whole blood, extracted DNA, or FTA card |
| Methodology Used | Targeted next‑generation sequencing (NGS) on Illumina platform with Sanger confirmation; ACMG variant classification |
| ICD-10-CM Code | I45.81 |
| LOINC Code | 81313-1 |
| DHA Facility License & Laboratory Address | License No. 1143 — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians